CRW.L

Craneware Plc
Craneware plc - Notice of Results Presentations
27th August 2024, 06:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 6884B
Craneware plc
27 August 2024
 

Craneware plc

 

("Craneware", the "Craneware Group", the "Company" or the "Group")

 

Notice of Results Presentations

 

27 August 2024 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, will announce its audited final results for the year ended 30 June 2024 on Tuesday, 3 September 2024.

 

Analyst Presentation

 

Keith Neilson, CEO, and Craig Preston, CFO, will host an in-person presentation for analysts at 09.00 BST on Tuesday, 3 September 2024 at the offices of Peel Hunt, 100 Liverpool Street, London EC2M 2AT.

 

To register to attend, please contact craneware@almastrategic.com

 

Investor Presentation

 

Management will also host a virtual presentation and Q&A session via the London Stock Exchange's SparkLive platform at 14.15 BST on Friday, 6 September 2024.

  

To register to attend, please use the following link: https://sparklive.lseg.com/Craneware/events/aa983951-cb57-4d91-ada4-cae2e0686596/craneware-plc-presents-its-fy24-interim-results

 

 

For further information, please contact:

 

Craneware plc

+44 (0)131 550 3100

Keith Neilson, CEO


Craig Preston, CFO

 

 


Alma Strategic Communications (Financial PR)

+44 (0)20 3405 0205

Caroline Forde, Kinvara Verdon

 

 

craneware@almastrategic.com

Peel Hunt (NOMAD and Joint Broker) 

+44 (0)20 7418 8900

Neil Patel, Benjamin Cryer, Kate Bannatyne

 

 


Investec Bank PLC (Joint Broker)

+44 (0)20 7597 5970

Patrick Robb, Henry Reast, Shalin Bhamra

 

 


Berenberg (Joint Broker)

+44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Dan Gee-Summons


 

 

About Craneware

 

The Craneware Group (AIM:CRW.L), is the market leader in value cycle solutions. For 25 years, we have collaborated with U.S. healthcare providers to optimize revenue integrity, pricing intelligence, decision support, labor productivity, business of pharmacy, and 340B program management.  

 

Customers choose Trisus®, a HITRUST- and SOC2 Type II-certified, SaaS-platform, to achieve operational and financial excellence in pursuit of their healthcare mission - delivering quality care to their communities. The Craneware Group - Transforming the Business of Healthcare.

 

Learn more at www.craneware.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORFLFFDTFIRFIS]]>
TwitterFacebookLinkedIn